Halozyme Therapeutics (HALO, $40.82) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 14, 2024

A.I.dvisor
at Tickeron.com
03/15/24
Loading...
HALO - Halozyme Therapeutics
MACD signal
Bearish Trend
Odds of DOWN Trend
MACD signal
Price: $40.82
Daily change: -$0.53 (-1.28%)
Daily volume: 1.1M
Capitalization: $5.2B
Industry: Biotechnology
This is a Bearish indicator signaling HALO's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 44 similar cases where HALO's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:
View a ticker or compare two or three
HALODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
373
Web
https://www.halozyme.com